Cannabis is the most widely produced and consumed illicit substance globally. A significant number of states have long engaged in soft defection from the UN drug control regime in relation to tolerant policies on the personal possession, cultivation and use of cannabis. Recently, there has been growing debate within political circles on the benefits of regulated cannabis markets. This has been driven by a number of factors, including the continuing illegality of supply, the associated and often violent involvement of criminal elements and the use of finite criminal justice resources. In this section you will find an overview of our most recent blogs on the issue.
Catalonia is drawing up rules to allow the use of marijuana for the treatment of patients suffering from conditions with symptoms such as pain and loss of appetite, the region's health minister Boi Ruiz has said. The move would open the way for the drug to be prescribed to cancer and AIDS patients, among others. The plan was partly designed to stop Barcelona's increasingly popular cannabis clubs from controlling the supply of medical marijuana, Ruiz said.
Cannabis was condemned by the 1961 Single Convention on Narcotic Drugs as a psychoactive drug with “particularly dangerous properties” and hardly any therapeutic value. Ever since, an increasing number of countries have shown discomfort with the treaty regime’s strictures through soft defections, stretching its legal flexibility to sometimes questionable limits.